Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dhanak

Showing results (121-130 of 143) with videos related to

Pageof 15
Sort By:
Bioorganic & Medicinal Chemistry Letters|June 7, 2005
Aminoalkoxybenzyl pyrrolidines as novel human urotensin-II receptor antagonistsJian Jin, Dashyant Dhanak, Steven D Knight, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2009
Substituted benzothiadizine inhibitors of Hepatitis C virus polymeraseAntony N Shaw, Rosanna Tedesco, Ramesh Bambal, et al.
Nature|May 23, 2014
SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancerPawel K Mazur, Nicolas Reynoird, Purvesh Khatri, et al.
Journal of the American Chemical Society|April 13, 2019
Stabilization of O-O Bonds by d<sup>0</sup> Cations in Li<sub>4+ x</sub>Ni<sub>1- x</sub>WO<sub>6</sub> (0 ≤ x ≤ 0.25) Rock Salt Oxides as the Origin of Large Voltage HysteresisZoe N Taylor, Arnaud J Perez, José A Coca-Clemente, et al.
Molecular Cancer Therapeutics|September 26, 2014
A687V EZH2 is a driver of histone H3 lysine 27 (H3K27) hypertrimethylationHeidi M Ott, Alan P Graves, Melissa B Pappalardi, et al.
Nature Chemical Biology|October 9, 2007
ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanismLusong Luo, Cynthia A Parrish, Neysa Nevins, et al.
Plos One|September 7, 2013
BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor modelsAnastasia Wyce, Gopinath Ganji, Kimberly N Smitheman, et al.
Nature|October 12, 2012
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutationsMichael T McCabe, Heidi M Ott, Gopinath Ganji, et al.
Journal of Medicinal Chemistry|February 3, 2006
3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, potent inhibitors of hepatitis C virus RNA-dependent RNA polymeraseRosanna Tedesco, Antony N Shaw, Ramesh Bambal, et al.
British Journal of Pharmacology|April 27, 2005
Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375Stephen A Douglas, David J Behm, Nambi V Aiyar, et al.
Pageof 15

Showing results (121-130 of 143) with videos related to

Sort By:
Pageof 15
Bioorganic & Medicinal Chemistry Letters|June 7, 2005
Aminoalkoxybenzyl pyrrolidines as novel human urotensin-II receptor antagonistsJian Jin, Dashyant Dhanak, Steven D Knight, et al.
Bioorganic & Medicinal Chemistry Letters|June 12, 2009
Substituted benzothiadizine inhibitors of Hepatitis C virus polymeraseAntony N Shaw, Rosanna Tedesco, Ramesh Bambal, et al.
Nature|May 23, 2014
SMYD3 links lysine methylation of MAP3K2 to Ras-driven cancerPawel K Mazur, Nicolas Reynoird, Purvesh Khatri, et al.
Journal of the American Chemical Society|April 13, 2019
Stabilization of O-O Bonds by d<sup>0</sup> Cations in Li<sub>4+ x</sub>Ni<sub>1- x</sub>WO<sub>6</sub> (0 ≤ x ≤ 0.25) Rock Salt Oxides as the Origin of Large Voltage HysteresisZoe N Taylor, Arnaud J Perez, José A Coca-Clemente, et al.
Molecular Cancer Therapeutics|September 26, 2014
A687V EZH2 is a driver of histone H3 lysine 27 (H3K27) hypertrimethylationHeidi M Ott, Alan P Graves, Melissa B Pappalardi, et al.
Nature Chemical Biology|October 9, 2007
ATP-competitive inhibitors of the mitotic kinesin KSP that function via an allosteric mechanismLusong Luo, Cynthia A Parrish, Neysa Nevins, et al.
Plos One|September 7, 2013
BET inhibition silences expression of MYCN and BCL2 and induces cytotoxicity in neuroblastoma tumor modelsAnastasia Wyce, Gopinath Ganji, Kimberly N Smitheman, et al.
Nature|October 12, 2012
EZH2 inhibition as a therapeutic strategy for lymphoma with EZH2-activating mutationsMichael T McCabe, Heidi M Ott, Gopinath Ganji, et al.
Journal of Medicinal Chemistry|February 3, 2006
3-(1,1-dioxo-2H-(1,2,4)-benzothiadiazin-3-yl)-4-hydroxy-2(1H)-quinolinones, potent inhibitors of hepatitis C virus RNA-dependent RNA polymeraseRosanna Tedesco, Antony N Shaw, Ramesh Bambal, et al.
British Journal of Pharmacology|April 27, 2005
Nonpeptidic urotensin-II receptor antagonists I: in vitro pharmacological characterization of SB-706375Stephen A Douglas, David J Behm, Nambi V Aiyar, et al.
Pageof 15